TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Xellia Pharmaceuticals ApS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,996,552
|
3,178,322
|
2,404,254 |
| Earnings before taxes |
-3,209,582
|
-360,400
|
-590,111 |
| Total assets |
3,174,802
|
4,898,127
|
5,007,604 |
| Current assets |
1,994,886
|
1,515,900
|
1,756,724 |
| Current liabilities |
3,081,694
|
1,550,626
|
1,218,533 |
| Equity capital |
-901,575
|
2,478,155
|
2,793,346 |
| - share capital |
303,152
|
284,524
|
269,579 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-28.4%
|
50.6%
|
55.8% |
| Turnover per employee |
8,562
|
9,081
|
6,869 |
| Profit as a percentage of turnover |
-107.1%
|
-11.3%
|
-24.5% |
| Return on assets (ROA) | |||
| Current ratio |
64.7%
|
97.8%
|
144.2% |
| Return on equity (ROE) |
356.0%
|
-14.5%
|
-21.1% |
| Change turnover |
-389,855
|
640,784
|
-335,149 |
| Change turnover % |
-12%
|
25%
|
-12% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.